DNA & Genetics Lundbeck Ends Bidding War for Avadel, After Alkermes’ Up-to-$2.37B OfferBy adminDecember 2, 20250 Lundbeck has ended its bidding war with Alkermes to acquire Avadel Pharmaceuticals, saying that it will not increase its offer for…
